Trial Of Kezar’s Only Active Drug Halted After Five Patients Die
The FDA has placed zetomipzomib on clinical hold a year after Kezar decided to focus solely on the product.
The FDA has placed zetomipzomib on clinical hold a year after Kezar decided to focus solely on the product.